MedPath

SYNPHASIC 21 TABLETS

SYNPHASIC 21 TABLETS

Discontinued
DIN Number

00620947

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

syntex inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00620947
AIG Number0414813001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AB04 NORETHISTERONE AND ESTROGEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

ETHINYL ESTRADIOLActive
Strength: .035 MG / TAB
Monograph: ETHINYL ESTRADIOL
NORETHINDRONEActive
Strength: 1 MG / TAB
Monograph: NORETHINDRONE
NORETHINDRONEActive
Strength: .5 MG / TAB
Monograph: NORETHINDRONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.